Mylan Pharmaceuticals Inc.: payments to doctors
Reported under the Physician Payments Sunshine Act for Open Payments program years 2019–2025. Figures group every CMS reporting entity belonging to this corporate parent.
- Total reported
- $26.9M
- Providers paid
- 7,810
- Transactions
- 16,961
- Average per transaction
- $1,583
The average per transaction — $1,583 — is the number worth reading. A large total spread across hundreds of thousands of transactions is a company buying a great many modest meals at educational presentations. A large total across few transactions means consulting, speaking or royalty arrangements with a small number of physicians. The totals alone do not distinguish them.
Where the money went
| State | Total reported | Share |
|---|---|---|
| Florida | $20,203,092 | 75.2% |
| Kansas | $4,686,222 | 17.5% |
| Arizona | $799,385 | 3.0% |
| Texas | $453,057 | 1.7% |
| New Jersey | $405,507 | 1.5% |
| New York | $35,513 | 0.1% |
| Illinois | $26,822 | 0.1% |
| District of Columbia | $26,238 | 0.1% |
| Ohio | $21,864 | 0.1% |
| Pennsylvania | $21,425 | 0.1% |
| North Carolina | $18,555 | 0.1% |
| Missouri | $18,118 | 0.1% |
| Alabama | $14,679 | 0.1% |
| Georgia | $14,496 | 0.1% |
| Tennessee | $14,018 | 0.1% |
| Maryland | $11,122 | 0.0% |
| Louisiana | $10,946 | 0.0% |
| California | $9,406 | 0.0% |
| Rhode Island | $9,371 | 0.0% |
| South Carolina | $8,410 | 0.0% |
| Virginia | $6,815 | 0.0% |
| Michigan | $5,932 | 0.0% |
| Arkansas | $5,305 | 0.0% |
| Kentucky | $4,893 | 0.0% |
| Massachusetts | $4,232 | 0.0% |
| Oklahoma | $3,781 | 0.0% |
| Indiana | $3,670 | 0.0% |
| Connecticut | $3,458 | 0.0% |
| Delaware | $1,945 | 0.0% |
| Nevada | $1,315 | 0.0% |
| Mississippi | $1,294 | 0.0% |
| Colorado | $945 | 0.0% |
| West Virginia | $814 | 0.0% |
| Utah | $711 | 0.0% |
| Nebraska | $379 | 0.0% |
| Washington | $242 | 0.0% |
| Oregon | $226 | 0.0% |
| Wisconsin | $189 | 0.0% |
| Montana | $181 | 0.0% |
| Hawaii | $139 | 0.0% |
| Minnesota | $136 | 0.0% |
| New Hampshire | $100 | 0.0% |
| Iowa | $71 | 0.0% |
| North Dakota | $28 | 0.0% |
| New Mexico | $21 | 0.0% |
| South Dakota | $19 | 0.0% |
| AP | $15 | 0.0% |
| Puerto Rico | $14 | 0.0% |
Products named in Mylan Pharmaceuticals Inc.'s payments
The drugs and devices most often named as the product a payment related to. A meal at a presentation about a product counts here, so this tracks what the company promotes as much as what it sells.
- Xulane$298,032
- Dymista$28,192
- Buprenorphine HCl and Naloxone HCl$18,060
- Yupelri$11,718
- Perforomist$11,512
- Olux$11,346
- Clindamycin Phosphate and Benzoyl Peroxide$11,125
- Olux-E$8,532
- Vusion$8,184
- Glatiramer Acetate$7,900
- Symfi Lo$2,701
- Cimduo$2,681
- Symfi$2,678
- Fulphila$90